Community Service: How Joshua J. Joseph, MD, MPH, Is Leveling the Healthcare Playing Field for All
Incarceration Nation: Administering Endocrine Healthcare in Our Nation’s Prisons
A first-of-its-kind session at ENDO 2024 will discuss healthcare management for the most underserved of the underserved: the incarcerated. The session, “Endocrine Care for Incarcerated Individuals,” will offer a detailed look at not only what it’s like to be incarcerated, but also the challenges of delivering appropriate endocrine treatment to this often unfairly stigmatized population....
The Root of the Problem: Warning Consumers About EDCs from the Laboratory Bench
Women Face Greater Risk of Obesity in Low- and Middle-Income Countries
Study finds women are 2-3 times more likely to be affected than men Women in low- and middle-income countries, especially in the Sub-Saharan Africa region, may be 10 times more likely to have obesity or heart health issues than their male counterparts, according to a large meta-analysis published in The Journal of Clinical Endocrinology and Metabolism....
Released in May, “Endocrine Health and Health Care Disparities in the Pediatric and Sexual and Gender Minority Populations: An Endocrine Society Scientific Statement,” was a featured session on the last day of ENDO 2023. Endocrine News spoke to some of the authors about these updated treatment protocols. Year after year, the Endocrine Society’s Annual Conferences...
Endocrine Society’s New Scientific Statement Identifies Research Gaps in Pediatric, LGBTQIA Care
In a new Scientific Statement released today, the Endocrine Society identifies areas for future endocrine research to reduce health disparities in pediatric and sexual and gender minoritized populations. This Scientific Statement expands the Society’s 2012 statement by focusing on endocrine disease disparities in the pediatric and sexual and gender minoritized populations. These include pediatric and...
Paraben Exposure Linked to Mammary Cancer Growth and Metastasis
Parabens like methylparaben (MP) and propylparaben (PP), which are commonly used in food, cosmetic, and drug preservatives, are associated with mammary cancer growth and metastasis in mice, according to a study recently published in Endocrinology. Researchers led by Michele A. La Merrill, PhD, of the Department of Environmental Toxicology at the University of California at...
Conversation Starters: Solutions to Overcome Health Disparities in Latinx Communities